Marco Zampoli

University Of Cape Town
Cape Town, WC, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Cystic fibrosis transmembrane conductance regulator modulator therapy and lived experiences in South Africa: A mixed-methods study.

Cystic fibrosis transmembrane conductance regulator modulator therapy and lived experiences in South Africa: A mixed-methods study.

Journal: The South African journal of physiotherapy

Published: May 26, 2026

Characterising cystic fibrosis in African populations: a scoping review protocol on phenotype, diagnosis, genetics and barriers to care.

Characterising cystic fibrosis in African populations: a scoping review protocol on phenotype, diagnosis, genetics and barriers to care.

Journal: BMJ open

Published: February 10, 2026

MDA5-associated juvenile dermatomyositis and interstitial lung disease from rapidly progressive to silent: a report of three cases in South African children and a review of the literature.

MDA5-associated juvenile dermatomyositis and interstitial lung disease from rapidly progressive to silent: a report of three cases in South African children and a review of the literature.

Journal: Clinical rheumatology

Published: September 18, 2025

Performance of the Experimental EuroQol Toddler and Infant Populations (EQ-TIPS) and PedsQL in Infants and Toddlers with a Health Condition.

Performance of the Experimental EuroQol Toddler and Infant Populations (EQ-TIPS) and PedsQL in Infants and Toddlers with a Health Condition.

Journal: Journal of health economics and outcomes research

Published: September 10, 2025

Patient-Derived Intestinal Organoids in the Global Cystic Fibrosis Landscape.

Patient-Derived Intestinal Organoids in the Global Cystic Fibrosis Landscape.

Journal: Pediatric pulmonology

Published: August 28, 2025

Global prevalence of CFTR variants with respect to their responsiveness to elexacaftor-tezacaftor-ivacaftor.

Global prevalence of CFTR variants with respect to their responsiveness to elexacaftor-tezacaftor-ivacaftor.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: August 25, 2025

Global Collaboration in Cystic Fibrosis: Lessons From the COVID-19 Pandemic for Low- and Middle-Income Countries.

Global Collaboration in Cystic Fibrosis: Lessons From the COVID-19 Pandemic for Low- and Middle-Income Countries.

Journal: Pediatric pulmonology

Published: August 18, 2025

Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis population.

Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis population.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: July 31, 2025

Cystic Fibrosis Care in South Africa: Facing the Challenge of Diversity and Inequality.

Cystic Fibrosis Care in South Africa: Facing the Challenge of Diversity and Inequality.

Journal: Pediatric pulmonology

Published: July 27, 2025

Expanding the experimental EuroQol toddler and infant populations (EQ-TIPS) descriptive system: comparing 3-level and 5-level performance for infants and toddlers with chronic conditions.

Expanding the experimental EuroQol toddler and infant populations (EQ-TIPS) descriptive system: comparing 3-level and 5-level performance for infants and toddlers with chronic conditions.

Journal: Journal of patient-reported outcomes

Published: July 15, 2025

Developing a collaborative network for cystic fibrosis in Africa: A call to action.

Developing a collaborative network for cystic fibrosis in Africa: A call to action.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: March 28, 2025

Real-world outcomes of generic elexacaftor/tezacaftor/ivacaftor (gETI) in South Africans (SA) with CF using standard versus clarithromycin-boosted gETI, modulator-sparing strategies to reduce cost.

Real-world outcomes of generic elexacaftor/tezacaftor/ivacaftor (gETI) in South Africans (SA) with CF using standard versus clarithromycin-boosted gETI, modulator-sparing strategies to reduce cost.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: October 18, 2024

Showing 1-12 of 68

Last Updated: 09/26/2026